Corvus Pharmaceuticals
CRVS
#6513
Rank
ยฃ0.62 B
Marketcap
ยฃ7.39
Share price
-3.40%
Change (1 day)
12.94%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2026 (TTM): -ยฃ0.46

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.47. In 2025 the company made an earnings per share (EPS) of -ยฃ0.12 an increase over its 2024 EPS that were of -ยฃ0.74.

EPS history for Corvus Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.46273.89%
2025-ยฃ0.12-83.51%
2024-ยฃ0.74
2022-ยฃ0.68-16.04%
2021-ยฃ0.81404.76%
2020-ยฃ0.16-86.79%
2019-ยฃ1.22-9.14%
2018-ยฃ1.34-35.66%
2017-ยฃ2.08-60.47%
2016-ยฃ5.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03 121.31%๐Ÿ‡บ๐Ÿ‡ธ USA